These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12530800)
1. The Sydney Medically Supervised Injecting Centre: a controversial public health measure. Kelly C; Conigrave KM Aust N Z J Public Health; 2002 Dec; 26(6):552-4. PubMed ID: 12530800 [TBL] [Abstract][Full Text] [Related]
2. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Salmon AM; van Beek I; Amin J; Kaldor J; Maher L Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794 [TBL] [Abstract][Full Text] [Related]
3. Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia. Kimber J; Dolan K J Urban Health; 2007 Mar; 84(2):255-66. PubMed ID: 17273925 [TBL] [Abstract][Full Text] [Related]
4. Health promotion at the Medically Supervised Injecting Centre. White M Aust Nurs J; 2012 Sep; 20(3):43. PubMed ID: 23066588 [No Abstract] [Full Text] [Related]
5. Expecting the unexpected: intravenous insulin at Sydney's medically supervised injecting centre. Jauncey ME; Trevan AP; Sulovsky RP Med J Aust; 2010 Apr; 192(8):477. PubMed ID: 20402617 [No Abstract] [Full Text] [Related]
6. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343 [TBL] [Abstract][Full Text] [Related]
7. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. van Beek I; Gilmour S Aust N Z J Public Health; 2000 Oct; 24(5):540-2. PubMed ID: 11109694 [TBL] [Abstract][Full Text] [Related]
8. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Kimber J; Mattick RP; Kaldor J; van Beek I; Gilmour S; Rance JA Drug Alcohol Rev; 2008 Nov; 27(6):602-12. PubMed ID: 19378444 [TBL] [Abstract][Full Text] [Related]
9. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia. Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940 [TBL] [Abstract][Full Text] [Related]
10. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Freeman K; Jones CG; Weatherburn DJ; Rutter S; Spooner CJ; Donnelly N Drug Alcohol Rev; 2005 Mar; 24(2):173-84. PubMed ID: 16076587 [TBL] [Abstract][Full Text] [Related]
11. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC). Goodhew M; Salmon AM; Marel C; Mills KL; Jauncey M Harm Reduct J; 2016 Oct; 13(1):29. PubMed ID: 27733167 [TBL] [Abstract][Full Text] [Related]
12. Injecting-related injury and disease among clients of a supervised injecting facility. Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171 [TBL] [Abstract][Full Text] [Related]
13. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre. Salmon AM; van Beek I; Amin J; Grulich A; Maher L Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850 [TBL] [Abstract][Full Text] [Related]
14. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. Kerr T; Small W; Moore D; Wood E Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342 [TBL] [Abstract][Full Text] [Related]
15. [The initial experience in supervised injecting facilities in Denmark]. Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221 [TBL] [Abstract][Full Text] [Related]
16. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods. Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037 [TBL] [Abstract][Full Text] [Related]
17. Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre. Latimer J; Ling S; Flaherty I; Jauncey M; Salmon AM Int J Drug Policy; 2016 Nov; 37():111-114. PubMed ID: 27750104 [No Abstract] [Full Text] [Related]
18. Drug consumption rooms: A systematic review of evaluation methodologies. Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M Drug Alcohol Rev; 2019 May; 38(4):406-422. PubMed ID: 30938025 [TBL] [Abstract][Full Text] [Related]
19. Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre. Roxburgh A; Darke S; Salmon AM; Dobbins T; Jauncey M Drug Alcohol Depend; 2017 Jul; 176():126-132. PubMed ID: 28535454 [TBL] [Abstract][Full Text] [Related]